Before this study, magnesium sulfate was demonstrated to be vasodilatory and neuroprotective
in animal models when administered within 2 h of ischemic stroke. The efficacy and
safety of magnesium sulfate in humans with acute ischemic stroke had not been demonstrated
previously.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2015 Published by Elsevier Inc.
